Dr. Tony Wyss-Coray

And what is really super exciting, we call this an age gap.

So the difference between your actual age and the estimated age of your organ.

And that's a very strong predictor of your future risk to develop disease in that organ.

So in other words, if your heart shows to age faster, you're more likely to get heart disease or a heart attack.

If your kidney ages fast, you're going to get kidney disease.

If your brain ages faster, you're more likely going to get Alzheimer's disease.

Yeah, so that's a great question.

We started a company with Paul Coletta called Vero Biosciences.

Vero?

Vero Biosciences.

And the mission is really to profile the age of organs to...

ideally eradicate chronic diseases and to maintain or to predict which organ is going to age.

Because what we find is that if you have an organ that ages faster, if you can detect that and you can do an intervention, you can potentially delay aging, right?

And extend health span.

And this is really the mission of Vero.

The Vero Compass uses a combination of this biological signature together with clinical and wearable data to create a platform that can predict how you respond, first of all, which organ is the most sensitive, which intervention you can use, and then whether your organ responds or not by repeated testing and sort of creating a continuous loop where

I tell you which organ is of concern.

You get medical advice based on other data that we can obtain from you.

And then you may get an intervention, could be a classic medical treatment,

But it could also be a change in your lifestyle, exercise, change of diet, type of exercise.